Uncoupling protein 2 in the glial response to stress:implications for neuroprotectionDaniel T. Hass, Colin J. Barnstable1197-1200
Selective neuronal PTEN deletion:can we take the brakes off of growth without losing control?Erin A Gutilla, Oswald Steward1201-1203
TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregenerationRicardo Ramírez-Barrantes, Ivanny Marchant, Pablo Olivero1204-1207
Tamoxifen:an FDA approved drug with neuroprotective effects for spinal cord injur y recover yJennifer M. Colón, Jorge D. Miranda1208-1211
Automatic counting of microglial cell activation and its applicationsBeatriz I Gallego Collado, Pablo de Gracia1212-1215
Prospects for bone marrow cell therapy in amyotrophic lateral sclerosis:how far are we from a clinical treatment?Fernanda Gubert, Marcelo F. Satiago1216-1219
Volume transmission and receptor-receptor interactions in heteroreceptor complexes:understanding the role of new concepts for brain communicationKjell Fuxe, Dasiel O Borroto-Escuela1220-1223
Guiding the migration of grafted cells to promote axon regenerationXiao-bing Yuan, Christopher Haas, Itzhak Fischer1224-1225
Potassium channel blockers restore axonal conduction in CNS trauma and diseasesJessica C. Page, Riyi Shi1226-1227
Ghrelin is the metabolic link connecting calorie restriction to neuroprotectionJacqueline A. Bayliss, Zane B. Andrews1228-1229
